Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy.

Literature DB >> 32116452

A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy.

Abstract

From a behavioral perspective, therapeutic inertia can happen when obstacles to changing a diabetes treatment plan outweigh perceived benefits. There is a complex interaction of important treatment-related obstacles for people with diabetes (PWD), their treating health care professional (HCP), and the clinical setting in which they interact. Tipping the scales toward more effective action involve strategies that increase perceptions of the benefits of treatment intensification while addressing important obstacles so that treatment changes are seen by both PWD and HCPs as worthwhile and achievable.

Entities: Disease Gene Species

Year: 2020 PMID： 32116452 PMCID： PMC7026761 DOI： 10.2337/ds19-0024

Source DB: PubMed Journal: Diabetes Spectr ISSN： 1040-9165

36 in total

Review 1. Clinical inertia.

Authors: L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal: Ann Intern Med Date: 2001-11-06 Impact factor: 25.391

2. Barriers and facilitators to self-care communication during medical appointments in the United States for adults with type 2 diabetes.

Authors: Marilyn D Ritholz; Elizabeth A Beverly; Kelly M Brooks; Martin J Abrahamson; Katie Weinger
Journal: Chronic Illn Date: 2014-02-24

3. Distress and type 2 diabetes-treatment adherence: A mediating role for perceived control.

Authors: Jeffrey S Gonzalez; Erica Shreck; Christina Psaros; Steven A Safren
Journal: Health Psychol Date: 2014-08-11 Impact factor: 4.267

4. Pathways for the relationship between diabetes distress, depression, fatalism and glycemic control in adults with type 2 diabetes.

Authors: Christopher C Asuzu; Rebekah J Walker; Joni Strom Williams; Leonard E Egede
Journal: J Diabetes Complications Date: 2016-09-30 Impact factor: 2.852

1. [Effect of dissipating phlegm and blood stasis simultaneously on AGEs/RAGE axis and oxidative stress in rats with diabetic myocardial microangiopathy].

Authors: X Xu; Q Chu; J Chu; Z Cai; Y Xuan; B Luo; S Li; J Chen; S Luo; Y Wang
Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2021-10-20

1 in total

A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy.

Review 1. Clinical inertia.

2. Barriers and facilitators to self-care communication during medical appointments in the United States for adults with type 2 diabetes.

3. Distress and type 2 diabetes-treatment adherence: A mediating role for perceived control.

4. Pathways for the relationship between diabetes distress, depression, fatalism and glycemic control in adults with type 2 diabetes.

Review 5. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019.

Review 6. Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes.

7. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

Review 8. Competing demands of primary care: a model for the delivery of clinical preventive services.

9. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

10. Predictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trials.

1. [Effect of dissipating phlegm and blood stasis simultaneously on AGEs/RAGE axis and oxidative stress in rats with diabetic myocardial microangiopathy].